Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents

Journal of Clinical Microbiology

Volumn 45, Issue 9, 2007, Pages 2819-2828

  Citron, Diane M ^a   Goldstein, Ellie J C ^a,b   Merriam, C Vreni ^a   Lipsky, Benjamin A ^c   Abramson, Murray A ^d  

^a R M ALDEN RESEARCH LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERTAPENEM; LEVOFLOXACIN; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AEROBIC CELL CULTURE; ANAEROBIC BACTERIUM; ANAEROBIC CELL CULTURE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; BACTEROIDES FRAGILIS; COAGULASE NEGATIVE STAPHYLOCOCCUS; DEBRIDEMENT; DIABETIC FOOT; DRUG CHOICE; ENTEROBACTERIACEAE; ENTEROCOCCUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; PORPHYROMONAS; PREVOTELLA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SKIN BIOPSY; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS;

ADULT; ANTI-INFECTIVE AGENTS; BACTERIA, AEROBIC; BACTERIA, ANAEROBIC; DIABETIC FOOT; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS;

BACTEROIDES FRAGILIS; CORYNEBACTERIUM; ENTEROBACTERIACEAE; ENTEROCOCCUS; NEGIBACTERIA; PORPHYROMONAS; POSIBACTERIA; PREVOTELLA; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS;

EID: 34548665257     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00551-07     Document Type: Article

References (57)

1. Abdulrazak, A., Z. I. Bitar, A. A. Al-Shamali, and L. A. Mobasher. 2005. Bacteriological study of diabetic foot infections. J. Diabetes Complications 19:138-141.
2. Armstrong, D. G., P. J. Liswood, and W. F. Todd. 1995. 1995 William J. Stickel Bronze Award. Prevalence of mixed infections in the diabetic pedal wound. A retrospective review of 112 infections. J. Am. Podiatr. Med. Assoc. 85:533-537.
3. Asfar, S. K., M. al-Arouj, A. al-Nakhi, A. Baraka, T. Juma, and M. Johny. 1993. Foot infections in diabetics: the antibiotic choice. Can. J. Surg. 36:170-172.
4. Bessman, A. N., P. J. Geiger, and H. Canawati. 1992. Prevalence of Corynebacteria in diabetic foot infections. Diabetes Care 15:1531-1533.
5. Bowler, P. G., and B. J. Davies. 1999. The microbiology of infected and noninfected leg ulcers. Int. J. Dermatol. 38:573-578.
6. Bowler, P. G., B. I. Duerden, and D. G. Armstrong. 2001. Wound microbiology and associated approaches to wound management. Clin. Microbiol. Rev. 14:244-269.
7. Candel Gonzalez, F. J., M. Alramadan, M. Matesanz, A. Diaz, F. Gonzalez-Roino, I. Candel, A. Calle, and J. J. Picazo. 2003. Infections in diabetic foot ulcers. Eur. J. Intern. Med. 14:341-343.
8. Chang, S., D. M. Sievert, J. C. Hageman, M. L. Boulton, F. C. Tenover, F. P. Downes, S. Shah, J. T. Rudrik, G. R. Pupp, W. J. Brown, D. Cardo, and S. K. Fridkin. 2003. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N. Engl. J. Med. 348:1342-1347.
9. Clinical and Laboratory Standards Institute. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 6th ed. CLSI document M7-A6. Clinical and Laboratory Standards Institute, Wayne, PA.
10. Clinical and Laboratory Standards Institute. 2006. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guidelines. CLSI document M45-A. Clinical and Laboratory Standards Institute, Wayne, PA.
11. Clinical and Laboratory Standards Institute. 2004. Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard, 6th ed. CLSI document M11-A6. Clinical and Laboratory Standards Institute, Wayne, PA.
12. Dang, C. N., Y. D. Prasad, A. J. Boulton, and E. B. Jude. 2003. Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet. Med. 20:159-161.
13. Davies, M. R., D. J. McMillan, R. G. Beiko, V. Barroso, R. Geffers, K. S. Sriprakash, and G. S. Chhatwal. 2007. Virulence profiling of Streptococcus dysgalactiae subspecies equisimilis isolated from infected humans reveals 2 distinct genetic lineages that do not segregate with their phenotypes or propensity to cause diseases. Clin. Infect. Dis. 44:1442-1454.
14. Diamantopoulos, E. J., D. Haritos, G. Yfandi, M. Grigoriadou, G. Margariti, O. Paniara, and S. A. Raptis. 1998. Management and outcome of severe diabetic foot infections. Exp. Clin. Endocrinol. Diabetes 106:346-352.
15. Diaz, C. G., J. Altclas, A. Jasovich, G. Mikaelian, G. Fiks, and E. Caro. 1992. Microbiology and conservative surgery of serious infections of the diabetic foot. Enferm. Infecc. Microbiol. Clin. 10:451-455.
16. Diekema, D. J., M. A. Pfaller, F. J. Schmitz, J. Smayevsky, J. Bell, R. N. Jones, and M. Beach. 2001. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 32(Suppl. 2):S114-S132.
17. El-Tahawy, A. T. 2000. Bacteriology of diabetic foot. Saudi Med. J. 21:344-347.
18. Embil, J. M., and E. Trepman. 2006. Microbiological evaluation of diabetic foot osteomyelitis. Clin. Infect. Dis. 42:63-65.
19. Fass, R. J., V. L. Helsel, J. Barnishan, and L. W. Ayers. 1986. In vitro susceptibilities of four species of coagulase-negative staphylococci. Antimicrob. Agents Chemother. 30:545-552.
20. Gadepalli, R., B. Dhawan, V. Sreenivas, A. Kapil, A. C. Ammini, and R. Chaudhry. 2006. A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care 29:1727-1732.
21. Ge, Y., D. MacDonald, H. Hait, B. Lipsky, M. Zasloff, and K. Holroyd. 2002. Microbiological profile of infected diabetic foot ulcers. Diabet. Med. 19:1032-1034.
22. Ge, Y., D. MacDonald, M. M. Henry, H. I. Hait, K. A. Nelson, B. A. Lipsky, M. A. Zasloff, and K. J. Holroyd. 1999. In vitro susceptibility to pexiganan of bacteria isolated from infected diabetic foot ulcers. Diagn. Microbiol. Infect. Dis. 35:45-53.
23. Gerding, D. N. 1995. Foot infections in diabetic patients: the role of anaerobes. Clin. Infect. Dis. 20(Suppl. 2):S283-S288.
24. Greig, J. M., and M. J. Wood. 2003. Staphylococcus lugdunensis vertebral osteomyelitis. Clin. Microbiol. Infect. 9:1139-1141.
25. Gu, J., H. Li, M. Li, C. Vuong, M. Otto, Y. Wen, and Q. Gao. 2005. Bacterial insertion sequence IS256 as a potential molecular marker to discriminate invasive strains from commensal strains of Staphylococcus epidermidis. J. Hosp. Infect. 61:342-348.
26. Hartemann-Heurtier, A., J. Robert, S. Jacqueminet, V. G. Ha, J. L. Golmard, V. Jarlier, and A. Grimaldi. 2004. Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact. Diabet. Med. 21:710-715.
27. Hellbacher, C., E. Tornqvist, and B. Soderquist. 2006. Staphylococcus lugdunensis: clinical spectrum, antibiotic susceptibility, and phenotypic and genotypic patterns of 39 isolates. Clin. Microbiol. Infect. 12:43-49.
28. Herchline, T. E., and L. W. Ayers. 1991. Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection. J. Clin. Microbiol. 29:419-421.
29. Hunt, J. A. 1992. Foot infections in diabetes are rarely due to a single microorganism. Diabet. Med. 9:749-752.
30. Johnson, S., F. Lebahn, L. R. Peterson, and D. N. Gerding. 1995. Use of an anaerobic collection and transport swab device to recover anaerobic bacteria from infected foot ulcers in diabetics. Clin. Infect. Dis. 20 (Suppl. 2):S289-S290.
31. Jousimies-Somer, H. R., P. Summanen, D. M. Citron, E. J. Baron, H. M. Wexler, and S. M. Finegold. 2002. Wadsworth-KTL anaerobic bacteriology manual. Star Publishing, Belmont, CA.
32. Lavery, L. A., D. G. Armstrong, R. P. Wunderlich, M. J. Mohler, C. S. Wendel, and B. A. Lipsky. 2006. Risk factors for foot infections in individuals with diabetes. Diabetes Care 29:1288-1293.
33. Lipsky, B. A., D. G. Armstrong, D. M. Citron, A. D. Tice, D. E. Morgenstern, and M. A. Abramson. 2005. Ertapenem versus piperacillin/ tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. Lancet 366:1695-1703.
34. Lipsky, B. A., A. R. Berendt, H. G. Deery, J. M. Embil, W. S. Joseph, A. W. Karchmer, J. L. LeFrock, D. P. Lew, J. T. Mader, C. Norden, and J. S. Tan. 2004. Diagnosis and treatment of diabetic foot infections. Clin. Infect. Dis. 39:885-910.
35. Lipsky, B. A., R. E. Pecoraro, S. A. Larson, M. E. Hanley, and J. H. Ahroni. 1990. Outpatient management of uncomplicated lower-extremity infections in diabetic patients. Arch. Intern. Med. 150:790-797.
36. Lipsky, B. A., R. E. Pecoraro, and L. J. Wheat. 1990. The diabetic foot. Soft tissue and bone infection. Infect. Dis. Clin. N. Am. 4:409-432.
37. Moran, G. J., A. Krishnadasan, R. J. Gorwitz, G. E. Fosheim, L. K. McDougal, R. B. Carey, and D. A. Talan. 2006. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355:666-674.
38. Murray, P. R., E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.). 2003. Manual of clinical microbiology, 8th ed. ASM Press, Washington, DC.
39. Nagamune, H., R. A. Whiley, T. Goto, Y. Inai, T. Maeda, J. M. Hardie, and H. Kourai. 2000. Distribution of the intermedilysin gene among the anginosus group streptococci and correlation between intermedilysin production and deep-seated infection with Streptococcus intermedius. J. Clin. Microbiol. 38:220-226.
40. Pathare, N. A., A. Bal, G. V. Talvalkar, and D. U. Antani. 1998. Diabetic foot infections: a study of microorganisms associated with the different Wagner grades. Indian J. Pathol. Microbiol. 41:437-441.
41. Pellizzer, G., M. Strazzabosco, S. Presi, F. Furlan, L. Lora, P. Benedetti, M. Bonato, G. Erle, and L. F. de. 2001. Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection. Diabet. Med. 18:822-827.
42. Razonable, R. R., D. G. Lewallen, R. Patel, and D. R. Osmon. 2001. Vertebral osteomyelitis and prosthetic joint infection due to Staphylococcus simulans. Mayo Clin. Proc. 76:1067-1070.
43. Refsahl, K., and B. M. Andersen. 1992. Clinically significant coagulase-negative staphylococci: identification and resistance patterns. J. Hosp. Infect. 22:19-31.
44. Rolston, K. V., P. Thirolf, D. S. Ho, and G. P. Bodey. 1985. Species dependent variability in the susceptibility of coagulase-negative staphylococci to various antimicrobial agents. J. Antimicrob. Chemother. 16:659-662.
45. Sapico, F. L., J. L. Witte, H. N. Canawati, J. Z. Montgomerie, and A. N. Bessman. 1984. The infected foot of the diabetic patient: quantitative microbiology and analysis of clinical features. Rev. Infect. Dis. 6(Suppl. 1):S171-S176.
46. Senneville, E., H. Melliez, E. Beltrand, L. Legout, M. Valette, M. Cazaubiel, M. Cordonnier, M. Caillaux, Y. Yazdanpanah, and Y. Mouton. 2006. Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures. Clin. Infect. Dis. 42:57-62.
47. Shankar, E. M., V. Mohan, G. Premalatha, R. S. Srinivasan, and A. R. Usha. 2005. Bacterial etiology of diabetic foot infections in South India. Eur. J. Intern. Med. 16:567-570.
48. Slater, R. A., T. Lazarovitch, I. Boldur, Y. Ramot, A. Buchs, M. Weiss, A. Hindi, and M. J. Rapoport. 2004. Swab cultures accurately identify bacterial pathogens in diabetic foot wounds not involving bone. Diabet. Med. 21:705-709.
49. Tattevin, P., P. Y. Donnio, and C. Arvieux. 2006. Coagulase-negative staphylococci in diabetic foot osteomyelitis. Clin. Infect. Dis. 42:1811-1812.
50. Udo, E. E., L. E. Jacob, and T. D. Chugh. 1995. Antimicrobial resistance of coagulase-negative staphylococci from a Kuwait hospital. Microb. Drug Resist. 1:315-320.
51. Viswanathan, V., J. J. Jasmine, C. Snehalatha, and A. Ramachandran. 2002. Prevalence of pathogens in diabetic foot infection in South Indian type 2 diabetic patients. J. Assoc. Physicians India 50:1013-1016.
52. von Eiff, C., G. Peters, and C. Heilmann. 2002. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect. Dis. 2:677-685.
53. Wall, I. B., C. E. Davies, K. E. Hill, M. J. Wilson, P. Stephens, K. G. Harding, and D. W. Thomas. 2002. Potential role of anaerobic cocci in impaired human wound healing. Wound Repair Regen. 10:346-353.
54. Warren, Y. A., K. L. Tyrrell, D. M. Citron, and E. J. Goldstein. 2006. Clostridium aldenense sp. nov. and Clostridium citroniae sp. nov. isolated from human clinical infections. J. Clin. Microbiol. 44:2416-2422.
55. Wheat, L. J., S. D. Allen, M. Henry, C. B. Kernek, J. A. Siders, T. Kuebler, N. Fineberg, and J. Norton. 1986. Diabetic foot infections. Bacteriologic analysis. Arch. Intern. Med. 146:1935-1940.
56. Yao, Y., D. E. Sturdevant, A. Villaruz, L. Xu, Q. Gao, and M. Otto. 2005. Factors characterizing Staphylococcus epidermidis invasiveness determined by comparative genomics. Infect. Immun. 73:1856-1860.
57. Zeillemaker, A. M., K. E. Veldkamp, M. G. van Kraaij, J. B. Hoekstra, A. A. Hoynck van Papendrecht, and R. J. Diepersloot. 1998. Piperacillin/tazobactam therapy for diabetic foot infection. Foot Ankle Int. 19:169-172.